Description
The Advanced Research Projects Agency for Health (ARPA-H) is hosting a Question and Answer (Q&A) Webinar for the Agentic AI-EnableD CardioVascular CAre TransfOrmation (ADVOCATE) program. The webinar will provide additional clarification on the ADVOCATE Innovation Solutions Opening (ISO) and address questions that may have arisen following the Proposers’ Day. The ADVOCATE program aims to revolutionize the management of patients with cardiovascular disease (CVD) by enabling the development of a clinically validated, regulatory-compliant, patient-facing, multimodal agentic system to support and deliver clinical care. The program will focus on developing a clinical AI Agent that provides care management to patients with chronic CVD and a Supervisory Agent that performs automated continuous monitoring and control of clinical agents.
• The ADVOCATE program is a two-phase, 39-month program.
• Multiple awards are anticipated for the ADVOCATE program.
• The program will support the development of independent agentic solutions that can continuously monitor and improve the clinical agentic AI deployed in clinical practice.
• The program will also enable the development of a blueprint for scalable deployment of a clinical supervised agentic AI system as a new member of the clinical team.
Attached files
Contact
Dr. Haider Warraich(Program Manager)